Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Nucleoside Drugs > Nicotinamide mononucleotide for Sale > NMN 12 true-NAD+Booster ultra stable nucleotide for skin revitalization, DNA repair&sirtuin activation
NMN 12 true-NAD+Booster ultra stable nucleotide for skin revitalization, DNA repair&sirtuin activation buy - large image1
NMN 12 true-NAD+Booster ultra stable nucleotide for skin revitalization, DNA repair&sirtuin activation buy - image1
NMN 12 true-NAD+Booster ultra stable nucleotide for skin revitalization, DNA repair&sirtuin activation buy - image2
NMN 12 true-NAD+Booster ultra stable nucleotide for skin revitalization, DNA repair&sirtuin activation buy - image3
NMN 12 true-NAD+Booster ultra stable nucleotide for skin revitalization, DNA repair&sirtuin activation buy - image4
NMN 12 true-NAD+Booster ultra stable nucleotide for skin revitalization, DNA repair&sirtuin activation buy - image5
NMN 12 true-NAD+Booster ultra stable nucleotide for skin revitalization, DNA repair&sirtuin activation buy - image6

NMN 12 true-NAD+Booster ultra stable nucleotide for skin revitalization, DNA repair&sirtuin activation

51 Inquiries

Unit Price:

$100-130/G FOB

Get Latest Price
CAS No.:

1094-61-7

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Qingdao

Brand:

SINOV

Packaging:

1 vial

Price valid (until):

2028-06-08

Company Type:
Trader
Location:
Hongkong, China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  



    1. Description

    Nicotinamide mononucleotide is also known as β-nicotinamide mononucleotide (NMN), which is a substrate for the synthesis of coenzyme I. At the same time, NMN is also used in anti-aging research. Studies have shown that β-NMN can also regulate insulin secretion and has an impact on mRNA expression levels. β-NMN has broad application prospects in the medical treatment field. β-Nicotinamide mononucleotide is the product of the reaction of extracellular nicotinamide phosphoribosyltransferase (eNAMPT) and a key NAD+ intermediate. It improves glucose tolerance by restoring the NAD+ level in mice with type 2 diabetes induced by high-fat diet. It also enhances liver insulin sensitivity and partially restores the expression of genes related to oxidative stress, inflammatory response, and circadian rhythm through SIRT1 activation.

    2. Application

    β- Nicotinamide mononucleotide is a precursor substance of the longevity protein's cofactor NAD+. NAD+ is an important coenzyme in the tricarboxylic acid cycle, promoting the metabolism of sugar, fat, and amino acids, and participating in energy synthesis; NAD+ is also the sole substrate of the consuming enzymes of coenzyme I (the sole substrate of DNA repair enzyme PARP, the sole substrate of longevity protein Sirtuins, and the sole substrate of cyclic ADP-ribose synthase CD38/157). NAD+ is involved in all aspects of human metabolism and is a crucial coenzyme. Without NAD+, metabolism cannot function properly. When the elderly lack NAD+, various large and small problems arise. By supplementing extra NAD+, one can comprehensively anti-aging. Preclinical studies have shown that NMN has various pharmacological activities in cardiac and cerebral ischemia, Alzheimer's disease, type 2 diabetes and obesity caused by diet and age. NMN, as a precursor drug of NAD+, mainly functions in the body to synthesize NAD+ and exert pharmacological effects. All of these are related to the deficiency of NAD+.

    3. Main Efficacy


    • β-Nicotinamide mononucleotide (β-NMN) is a naturally occurring and bioactive nucleotide that serves as the main source of cellular energy. It has antioxidant, anti-oxidative stress reduction, and anti-inflammatory effects. It offers the following benefits for the human body:

    • (1) Studies have shown that by supplementing exogenous β-NMN to increase the content of NAD+ and NADH in the heart, it mimics the protective effect of IPC and enhances deacetylase activity, reducing infarct area, and achieving heart protection. When abnormal blood circulation occurs in the brain, it can trigger an acute cerebrovascular disease, and β-NMN has an improving effect on such situations.

    • (2) Improving oxidative-related degenerative diseases and physical functional disorders Research shows that β-NMN can more directly and effectively increase NAD+ levels, promote the activation of the longevity factor Sirtuin Sirt1, achieve the effect of reducing cell damage and maintaining collagen, avoid skin dryness, wrinkling, collapse, relaxation and fine lines, thereby delaying skin aging. Cardiovascular diseases mainly occur due to irregular relaxation and contraction of myocardial cells, so treating cardiovascular diseases requires repairing and enhancing the energy of mitochondria in myocardial cells.

    • (3) Therapeutic effects on metabolic diseases β-NMN can promote the biosynthesis of NAD+, and Nampt-mediated NAD+ biosynthesis is crucial for cell function, regulating insulin secretion of pancreatic islet cells and reducing blood sugar.

    Shop Professional Factory Supply High Qulity Bengenin-Detailed Image 2

    Shop Cosmetic Raw Materials Hyaluronic Acid Powder-Detailed Image 2

    Items Specifications
    Origin China
    Purity

    5%-99%

    Appearance Powder
    Color White
    Package

    Drum, Plastic Container, Vacuum Packed

    Shelf life

    2 years

    Storage

    Cool Dry Place

    ECHEMI Editorial Reference
    β-nicotinamide mononucleotide is an intermediate in NAD+ biosynthesis produced from nicotinamide (NAM) and phosphoribosyl pyrophosphate (PRPP) by nicotinamide phosphoribosyl transferase enzyme.
    NMN zwitterion is a nicotinamide mononucleotide. It has a role as an Escherichia coli metabolite and a mouse metabolite. It is a conjugate base of a NMN(+). It is a conjugate acid of a NMN(-).|3-Carbamoyl-1-beta-D-ribofuranosyl pyridinium hydroxide-5'phosphate, inner salt. A nucleotide in which the nitrogenous base, nicotinamide, is in beta-N-glycosidic linkage with the C-1 position of D-ribose. Synonyms: Nicotinamide Ribonucleotide; NMN.

    Basic Info
    Product Name:

    Nicotinamide mononucleotide

    Other Name:

    Pyridinium,3-(aminocarbonyl)-1-(5-O-phosphono-β-D-ribofuranosyl)-,inner salt;Pyridinium,3-carbamoyl-1-β-D-ribofuranosyl-,hydroxide,5′-(dihydrogen phosphate),inner salt;Pyridinium,3-(aminocarbonyl)-1-(5-O-phosphono-β-D-ribofuranosyl)-,hydroxide,inner salt;3-Carbamoyl-1-β-D-ribofuranosylpyridinium hydroxide,5′-phosphate,inner salt;Nicotinamide mononucleotide;Nicotinamide ribonucleotide;NMN;Nicotinamide ribotide;β-NMN;Nicotinamide ribonucleoside 5′-phosphate;NMN (mononucleotide);β-D-NMN;27626-81-9;1140909-84-7

    CAS No.:

    1094-61-7

    Molecular Formula:

    C11H15N2O8P

    InChIKeys:

    InChIKey=DAYLJWODMCOQEW-TURQNECASA-N

    Molecular Weight:

    334.22

    Exact Mass:

    334.056610

    EC Number:

    214-136-5

    UNII:

    2KG6QX4W0V

    Categories:

    Nucleoside Drugs

    Characteristics
    PSA:

    166

    XLogP3:

    -3.5

    Storage Conditions:

    2-8°C

    Collision Cross Section:

    165.2 Ų [M]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|165.2 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|167.13 Ų [M+H]+ [CCS Type: DT, Method: stepped-field]|166 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|165.8 Ų [M+H]+

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

    Location:

    Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    51-100

    Year of Establishment:

    2012

    We have more than 10 years experience in the pharmacy filed. Mainly manufactures pharmaceutical APIs,Pharmaceutical intermediate and Cosmetic raw material. Owing to the good quality and competitive price, we have a very good reputation in China's pharmaceutical circles.

    In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System.

    Our products are based on bulk, high volume, wholesale price, third party testing, certificate reporting, and bring high quality ingredients to many domestic and overseas enterprises.

    "Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.

  • Inquiry History
    51 Inquiries
    Country Product Purchase Quantity Date Posted
    Australia

    NMN β-Nicotinamide Mononucleotide 1094-61-7 99.5% Uthever

    50 KG Nov 17, 2023
    Philippines

    β-NMN bulk powder 1094-61-7 Purity 99.9% food grade Beta Nicotinamide Mononucleotide powder

    500 G Jul 17, 2025
    India

    Beta-Nicotinamide Mononucleotide

    1 KG Jan 19, 2026
    India

    NMN

    1.00 KG Dec 21, 2023
    Romania

    NMN (beta-Nicotinamide Mononucleotide)

    1 KG Oct 22, 2026
    India

    Nicotinamide mononucleotide (NMN)

    300.00 KG Sep 4, 2026
    India

    Nicotinamide mononucleotide (NMN)

    50.00 KG Aug 26, 2026
    Pakistan

    Nicotinamide

    500.00 KG Jul 24, 2026
    India

    Nicotinamide mononucleotide

    50 G Apr 8, 2026
    United States

    NMN

    100 G Mar 14, 2026
    India

    Niacinamide

    75.00 KG Feb 25, 2026
    Australia

    NMN

    1 KG Feb 21, 2026
    Indonesia

    Nicotinamide mononucleotide NMN

    1 KG Oct 13, 2025
    Australia

    NMN

    1 KG Nov 1, 2024
    United States

    β-Nicotinamid Mononucleotide

    1 KG Sep 26, 2024
    South Korea

    b-NMN

    1 KG May 30, 2024
    Vietnam

    NMN

    1 MT May 24, 2024
    United States

    NMN

    1 MT Mar 7, 2024
    Australia

    NMN

    50 KG Dec 12, 2023
    Peru

    NMN

    1 KG Nov 29, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.